These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7802869)

  • 21. Crystallographic structure of the SH3 domain of the human c-Yes tyrosine kinase: loop flexibility and amyloid aggregation.
    Martín-García JM; Luque I; Mateo PL; Ruiz-Sanz J; Cámara-Artigas A
    FEBS Lett; 2007 May; 581(9):1701-6. PubMed ID: 17418139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
    Liu J; Li M; Ran X; Fan JS; Song J
    Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
    Hou T; McLaughlin W; Lu B; Chen K; Wang W
    J Proteome Res; 2006 Jan; 5(1):32-43. PubMed ID: 16396493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of the N-terminal SH3 domain of mouse betaPIX, p21-activated kinase-interacting exchange factor.
    Li X; Liu X; Sun F; Gao J; Zhou H; Gao GF; Bartlam M; Rao Z
    Biochem Biophys Res Commun; 2006 Jan; 339(1):407-14. PubMed ID: 16307729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis of PxxDY motif recognition in SH3 binding.
    Aitio O; Hellman M; Kesti T; Kleino I; Samuilova O; Pääkkönen K; Tossavainen H; Saksela K; Permi P
    J Mol Biol; 2008 Sep; 382(1):167-78. PubMed ID: 18644376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
    Feng S; Chen JK; Yu H; Simon JA; Schreiber SL
    Science; 1994 Nov; 266(5188):1241-7. PubMed ID: 7526465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel peptide-SH3 interaction.
    Mongioví AM; Romano PR; Panni S; Mendoza M; Wong WT; Musacchio A; Cesareni G; Di Fiore PP
    EMBO J; 1999 Oct; 18(19):5300-9. PubMed ID: 10508163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The GTPase dynamin binds to and is activated by a subset of SH3 domains.
    Gout I; Dhand R; Hiles ID; Fry MJ; Panayotou G; Das P; Truong O; Totty NF; Hsuan J; Booker GW
    Cell; 1993 Oct; 75(1):25-36. PubMed ID: 8402898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competitive binding assay of src homology domain 3 interactions between 5-lipoxygenase and growth factor receptor binding protein 2.
    VanderNoot VA; Fitzpatrick FA
    Anal Biochem; 1995 Sep; 230(1):108-14. PubMed ID: 8585605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical residues in an SH3 domain from Sem-5 suggest a mechanism for proline-rich peptide recognition.
    Lim WA; Richards FM
    Nat Struct Biol; 1994 Apr; 1(4):221-5. PubMed ID: 7656049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos.
    Goudreau N; Cornille F; Duchesne M; Parker F; Tocqué B; Garbay C; Roques BP
    Nat Struct Biol; 1994 Dec; 1(12):898-907. PubMed ID: 7773779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability and peptide binding affinity of an SH3 domain from the Caenorhabditis elegans signaling protein Sem-5.
    Lim WA; Fox RO; Richards FM
    Protein Sci; 1994 Aug; 3(8):1261-6. PubMed ID: 7987221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SH3 domain ligand binding: What's the consensus and where's the specificity?
    Saksela K; Permi P
    FEBS Lett; 2012 Aug; 586(17):2609-14. PubMed ID: 22710157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk.
    Wu X; Knudsen B; Feller SM; Zheng J; Sali A; Cowburn D; Hanafusa H; Kuriyan J
    Structure; 1995 Feb; 3(2):215-26. PubMed ID: 7735837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution crystal structure of spectrin SH3 domain fused with a proline-rich peptide.
    Gushchina LV; Gabdulkhakov AG; Nikonov SV; Filimonov VV
    J Biomol Struct Dyn; 2011 Dec; 29(3):485-95. PubMed ID: 22066535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the N-terminal SH3 domain of GRB2 complexed with a peptide from the guanine nucleotide releasing factor Sos.
    Terasawa H; Kohda D; Hatanaka H; Tsuchiya S; Ogura K; Nagata K; Ishii S; Mandiyan V; Ullrich A; Schlessinger J
    Nat Struct Biol; 1994 Dec; 1(12):891-7. PubMed ID: 7773778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel recognition mode between Vav and Grb2 SH3 domains.
    Nishida M; Nagata K; Hachimori Y; Horiuchi M; Ogura K; Mandiyan V; Schlessinger J; Inagaki F
    EMBO J; 2001 Jun; 20(12):2995-3007. PubMed ID: 11406576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orientation of peptide fragments from Sos proteins bound to the N-terminal SH3 domain of Grb2 determined by NMR spectroscopy.
    Wittekind M; Mapelli C; Farmer BT; Suen KL; Goldfarb V; Tsao J; Lavoie T; Barbacid M; Meyers CA; Mueller L
    Biochemistry; 1994 Nov; 33(46):13531-9. PubMed ID: 7947763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence analysis identifies a ras-associating (RA)-like domain in the N-termini of band 4.1/JEF domains and in the Grb7/10/14 adapter family.
    Wojcik J; Girault JA; Labesse G; Chomilier J; Mornon JP; Callebaut I
    Biochem Biophys Res Commun; 1999 May; 259(1):113-20. PubMed ID: 10334925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of the mammalian Grb2 adaptor.
    Maignan S; Guilloteau JP; Fromage N; Arnoux B; Becquart J; Ducruix A
    Science; 1995 Apr; 268(5208):291-3. PubMed ID: 7716522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.